Matinas BioPharma Holdings, Inc. (MTNB) Operating cash flow 2016–2025
Matinas BioPharma Holdings, Inc. (MTNB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2025 · since FY2016: -$6.1M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | +55.9% |
| FY2024 | -$15.9M | -4.0% |
| FY2023 | -$15.3M | +20.2% |
| FY2022 | -$19.2M | -25.8% |
| FY2021 | -$15.2M | +12.3% |
| FY2020 | -$17.4M | -23.2% |
| FY2019 | -$14.1M | -36.5% |
| FY2018 | -$10.3M | +9.9% |
| FY2017 | -$11.5M | -87.3% |
| FY2016 | -$6.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice